Congress moves to make birth control available without a prescription
H.R. 8083 — Allowing Greater Access to Safe and Effective Contraception Act · Filed by Ashley Hinson (R-IA) · 3 cosponsors · Introduced Mar 25, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the FDA to fast-track approval of over-the-counter oral contraceptive drugs for adults 18 and older, waives FDA application fees for such drugs, and requires a Government Accountability Office study of federal spending on contraception over the past 15 years across Medicare, Medicaid, military health, and other programs. Minors remain subject to existing prescription requirements.
Why we flagged it
The bill's core mechanism is regulatory streamlining—fast-track FDA review and fee waiver—designed to move oral contraceptives from prescription to over-the-counter status for adults. The GAO study is a secondary transparency measure.
What the text implies
- Fee waiver reduces FDA revenue from drug application fees; magnitude depends on number of supplemental applications filed but is likely modest.
- Priority review may accelerate approval timelines, potentially reducing FDA's ability to conduct thorough safety review if resources are not adjusted.
The full analysis lists 5 implications of this text.
Who stands to gain
oral contraceptive manufacturers (faster approval, fee waiver); pharmacies (new OTC sales channel); women aged 18+ (reduced out-of-pocket costs from eliminated doctor visits)